Study: FDG-PET scans may lead to misdiagnosis of Alzheimer's

04/26/2012 | Medscape (free registration)

Sixty-five percent of patients in a community setting had a misdiagnosis or inconclusive data after an FDG-PET scan for Alzheimer's disease, with 35% having false-positive results, according to a study presented at a neurology meeting. The study indicates a need to standardize protocols for reading results, an expert said. Another expert has expressed concern over the findings, particularly with the arrival of new PET tracers for Alzheimer's.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health